Your browser doesn't support javascript.
loading
Hyperglucagonemia Does Not Explain the ß-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study.
Kahn, Steven E; Mather, Kieren J; Arslanian, Silva A; Barengolts, Elena; Buchanan, Thomas A; Caprio, Sonia; Ehrmann, David A; Hannon, Tamara S; Marcovina, Santica; Nadeau, Kristen J; Utzschneider, Kristina M; Xiang, Anny H; Edelstein, Sharon L.
Afiliação
  • Kahn SE; VA Puget Sound Health Care System, Seattle, WA.
  • Mather KJ; University of Washington, Seattle, WA.
  • Arslanian SA; Indiana University School of Medicine, Indianapolis, IN.
  • Barengolts E; UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
  • Buchanan TA; Jesse Brown VA Medical Center, Chicago, IL.
  • Caprio S; Keck School of Medicine of University of Southern California, Los Angeles, CA.
  • Ehrmann DA; Yale University, New Haven, CT.
  • Hannon TS; University of Chicago, Chicago, IL.
  • Marcovina S; Indiana University School of Medicine, Indianapolis, IN.
  • Nadeau KJ; University of Washington, Seattle, WA.
  • Utzschneider KM; University of Colorado Denver, Aurora, CO.
  • Xiang AH; VA Puget Sound Health Care System, Seattle, WA.
  • Edelstein SL; University of Washington, Seattle, WA.
Diabetes Care ; 44(9): 1961-1969, 2021 09.
Article em En | MEDLINE | ID: mdl-34131047
ABSTRACT

OBJECTIVE:

To determine whether ß-cell hyperresponsiveness and insulin resistance in youth versus adults in the Restoring Insulin Secretion (RISE) Study are related to increased glucagon release. RESEARCH DESIGN AND

METHODS:

In 66 youth and 350 adults with impaired glucose tolerance (IGT) or recently diagnosed type 2 diabetes (drug naive), we performed hyperglycemic clamps and oral glucose tolerance tests (OGTTs). From clamps we quantified insulin sensitivity (M/I), plasma fasting glucagon and C-peptide, steady-state glucagon and C-peptide at glucose of 11.1 mmol/L, and arginine-stimulated glucagon (acute glucagon response [AGR]) and C-peptide (ACPRmax) responses at glucose >25 mmol/L.

RESULTS:

Mean ± SD fasting glucagon (7.63 ± 3.47 vs. 8.55 ± 4.47 pmol/L; P = 0.063) and steady-state glucagon (2.24 ± 1.46 vs. 2.49 ± 1.96 pmol/L, P = 0.234) were not different in youth and adults, respectively, while AGR was lower in youth (14.1 ± 5.2 vs. 16.8 ± 8.8 pmol/L, P = 0.001). Significant age-group differences in insulin sensitivity, fasting C-peptide, steady-state C-peptide, and ACPRmax were not related to glucagon. Fasting glucose and glucagon were positively correlated in adults (r = 0.133, P = 0.012) and negatively correlated in youth (r = -0.143, P = 0.251). In both age-groups, higher fasting glucagon was associated with higher fasting C-peptide (youth r = 0.209, P = 0.091; adults r = 0.335, P < 0.001) and lower insulin sensitivity (youth r = -0.228, P = 0.066; adults r = -0.324, P < 0.001). With comparable fasting glucagon, youth had greater C-peptide and lower insulin sensitivity. OGTT suppression of glucagon was greater in youth.

CONCLUSIONS:

Youth with IGT or recently diagnosed type 2 diabetes (drug naive) have hyperresponsive ß-cells and lower insulin sensitivity, but their glucagon concentrations are not increased compared with those in adults. Thus, α-cell dysfunction does not appear to explain the difference in ß-cell function and insulin sensitivity in youth versus adults.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Diabetes Mellitus Tipo 2 Limite: Adolescent / Adult / Humans Idioma: En Revista: Diabetes Care Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Diabetes Mellitus Tipo 2 Limite: Adolescent / Adult / Humans Idioma: En Revista: Diabetes Care Ano de publicação: 2021 Tipo de documento: Article